Could a TB vaccine stop diabetes? new trial hopes so
NCT ID NCT05591339
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether the BCG vaccine, normally used for tuberculosis, can prevent type 2 diabetes in people with pre-diabetes. Researchers in Guinea-Bissau will give two doses of BCG or a placebo to 200 adults and track their blood sugar levels. The goal is to see if the vaccine reduces inflammation and insulin resistance, potentially stopping pre-diabetes from becoming full-blown diabetes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
BCG vaccine
What this could lead to
If it works, this could point toward a low-cost way to prevent type 2 diabetes in at-risk populations.
What could go wrong
This is a small, early-phase trial in one country, so results may not apply elsewhere. The BCG vaccine can cause local reactions and is not proven for diabetes prevention.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bandim Health Project
Bissau, 1004, Guinea-Bissau